Bayer inks molecular imaging deal

Bayer Schering Pharma has signed a license agreement with South Korean molecular imaging manufacturer FutureChem.

Under the deal, Berlin-based Bayer Schering Pharma gains exclusive worldwide rights to a proprietary fluorine-18 radiolabeling technology used for molecular imaging applications. FutureChem and Asan Medical Center in Seoul have developed labeling technology that includes a nucleophilic substitution reaction in protic solvent, Bayer Schering Pharma said.

Related Reading

Bayer launches VistaTrak at RSNA show, December 3, 2007

Bayer HealthCare secures 3-year MRI contract, November 9, 2007

Bayer Schering Pharma licenses Avid's imaging agent, June 19, 2007

Bayer details job cuts, Schering integration, March 5, 2007

Bayer Schering to develop PET brain imaging agents, January 19, 2007

Copyright © 2008 AuntMinnie.com

Page 1 of 1262
Next Page